Star51 Capital
Corporate VCActively deployingNew York
Investment thesis
Star51 Capital invests at the intersection of Medtech and AI, positioning itself as a bridge between innovation and acquisition. Backed by a leading healthcare system and a top-5 global Medtech strategic, the fund provides portfolio companies with clinical validation, commercialization pathways, and domain expertise in addition to capital. Managed by founders-turned-investors who have built, scaled, and exited Medtech companies, the firm sources high-conviction opportunities from the US, Europe, and Israel. Its integrated ecosystem model is designed to build startups that are attractive acquisition targets for strategic buyers.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 1 of 1 portfolio companiesBiotech Γ1Healthtech Γ1
HQs:United StatesΓ1
Investments Β· 1 tracked
founders shown can be your intro pathBiotechHealthtechBraintree, US
Harel Gadot(Executive Officer, Director)Rachel Vaknin(Executive Officer)SIMON SHARON(Executive Officer)Juan Diaz-Cartelle(Executive Officer)Moshe Shoham(Director)Yoav Waizer(Director)
Board seatTal WenderowΒ· per SEC Form D Β· $25.2M raise Β· filed Sep 2025
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.
Exits Β· 1
IPOs and acquisitions across the tracked portfolioMicrobot Medical Inc.NASDAQ: MBOT
Frequently asked questions
- What sectors does Star51 Capital focus on?
- Star51 Capital focuses on AI & Machine Learning, Healthtech, Medical Devices.
- Where is Star51 Capital located?
- Star51 Capital is headquartered in New York, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.